期刊文献+

柴牡醒脑汤合康复干预对脑卒中后认知功能障碍的影响 被引量:13

Effect of Chaimuxingnao Decoction and Rehabilitation Interventions on Cognitive Dysfunction after Cerebral Apoplexy
下载PDF
导出
摘要 目的观察柴牡醒脑汤合康复干预治疗脑卒中后认知功能障碍的临床疗效。方法 53例脑卒中后认知功能障碍患者随机分为观察组27例和对照组26例。观察组采用神经内科常规治疗+康复干预+柴牡醒脑汤口服,对照组采用神经内科常规治疗+康复干预。以治疗后两组患者脑神经行为认知状况测定(NCSE)量表评定积分评价疗效。结果两组NCSE积分均较治疗前显著改善(P<0.05)。观察组有效率为88.89%,优于对照组的69.23%(P<0.05)。结论柴牡醒脑汤能明显促进脑卒中患者认知功能障碍的恢复。 Objective To observe the therapeutic effect of treatment with Chaimuxingnao decoction and rehabili-tation interventions on cognitive dysfunction in patients suffering from cerebral apeplexy. Methods Totally 53 pa-tients diagnosed as having cognitive dysfunction with cerebral apoplexy were divided randomly into compound group (n=27)and control group(n=26). Patients from compound group took regular treatment of internal medicine + Chaimux-ingnao decoction + rehabilitation interventions and patients from control group took regular treatment of internal medicine + rehabilitation interventions. The neurobehavioral status examination(NCSE) test was performed to evalu-ate efficacy after treatment. Results The effective rate of compound group was 88.89%, higher than 69.23% of control group(P<0.05). The scores of NCSE showed improvement after treatment both in compound and control groups (P<0.05). Conclusion Treatment with Chaimuxingnao decoction can have protective effect against cognitive dys-function in patients with cerebral apoplexy.
出处 《浙江中西医结合杂志》 2014年第1期3-4,13,共3页 Zhejiang Journal of Integrated Traditional Chinese and Western Medicine
基金 浙江省中医药科技计划项目(No.2011ZB165)
关键词 脑卒中 认知功能障碍 柴牡醒脑汤 康复干预 cerebral apoplexy cognitive dysfunction Chaimuxingnao decoction
  • 相关文献

参考文献8

二级参考文献43

  • 1隋建峰,熊鹰,张长城.一种用于大鼠被动回避行为训练的多功能条件反射箱[J].第三军医大学学报,1994,16(5):363-364. 被引量:20
  • 2刘卫刚,肖向建,李敏,马征,李春岩.石杉碱甲对体外培养大鼠脊髓片前角运动神经元损伤的保护作用[J].中国新药与临床杂志,2005,24(12):933-937. 被引量:9
  • 3肖淑萍,吉中国.银杏叶提取物对经铝化物诱导的阿尔茨海默病模型大鼠的影响[J].中国基层医药,2006,13(3):405-408. 被引量:5
  • 4郑瞻培.修改后的长谷川式简易智能评定量表[J].国外医学:精神病学分册,1993,20(1):40-40.
  • 5Court JA,Perry EK,Kalaria RN.Neurotransmitter control of the cerebral vasculature and abnormalities in vascular dementia.In:Erkinjuntti T,Gauthier S,eds.Vascular Cognitive Impairment[M].London:Martin Duniz Ltd,2002:167-185.
  • 6Black SE,Doody R,Li H,et al.Donepezil preserves cognition and global function in patients with severe Alzheimer disease[J].Neurology,2007,69(5):459-469.
  • 7Lu PH,Edland SD,Teng E,et al.Donepezil delaysprogression to AD in MCI subjects with depressive symptoms[J].Neurology,2009,72(24):2115-2121.
  • 8Aupperle PM,Koumaras B,Chert M,et al.Long-term effects of rivastigmine treatment on neuropsychiatric and behavioral disturbances in nursing home residents with moderate to severe Alzheimer's disease:results of a 52-week open-label study[J].Curr Med Res Opin,2004,20(10):1605-1612.
  • 9Frankfort SV,Appels BA,de Boer A,et al.Identification of responders and reactive domains to rivastigmine in Alzheimer's disease[J].Pharmacoepidemiol Drug Saf,2007,16(5):545-551.
  • 10Moretti R,Torte P,Antonello RM,et al.Different responses to rivastigmine in subcortical vascular dementia and multiinfarct dementia[J].Am J Alzheimers Dis Other Demen,2008,23(2):167-176.

共引文献37894

同被引文献202

引证文献13

二级引证文献124

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部